炎症性肠病的血栓栓塞风险和防治进展  

Risk and Prevention of Thromboembolism in Inflammatory Bowel Disease

作　　者：俞文 阿依努尔·吾布力卡斯木 姑丽皮叶·艾尼瓦尔 艾克帕尔·艾肯 哈斯也提·艾力 王吉林[2] 朱健康 YU Wen;AYINUER·Wubulikasimu;GULIPIYE·Ainiwaer;AIKEPAER·Aiken;HASIYETI·Aili;WANG Jilin;ZHU Jiankang(Department of Gastroenterology,Kashgar Prefecture Second People′s Hospital,Kashgar Region,Xinjiang Uygur Autonomous Region,844000;Division of Gastroenterology and Hepatology,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai)

机构地区：[1]新疆维吾尔自治区喀什地区第二人民医院消化内科,844000 [2]上海交通大学医学院附属仁济医院消化内科

出　　处：《胃肠病学》2023年第8期509-512,共4页Chinese Journal of Gastroenterology

摘　　要：炎症性肠病(IBD)病程反复、常迁延不愈,近来我国IBD发病率正处于快速上升期。IBD患者合并血栓栓塞的风险显著增加,是造成IBD患者预后不良的重要原因之一,但其血栓栓塞的病理、生理机制尚未完全明确,且尚未引起临床医师的足够重视。本文拟就IBD血栓栓塞的发生风险和发生机制作一综述,同时总结其防治策略方面的进展,以期对IBD患者的血栓栓塞防治有所帮助。The incidence rate of inflammatory bowel disease(IBD)in China is in a rapid rise period in recent years,and the course of the disease is repeated and prolonged.The risk of IBD combined with thromboembolism is significantly increased,and it is one of the important reasons for poor prognosis of IBD patients.However,the pathological and physiological mechanisms of thromboembolism have not been fully understood and have not received sufficient attention from clinical physicians.This article aims to provide a systematic review of the risks and mechanisms of thromboembolism in IBD,and to summarize the progress in its prevention and treatment strategies,in order to be helpful for the prevention and treatment of thromboembolism in IBD patients.

关 键 词：炎症性肠病 血栓栓塞 机制 预防 治疗 

分 类 号：R574[医药卫生—消化系统]